Observations on the pharmacology of glaucoma.
Leopold
I H
IH
Duzman
E
E
D000067956:Adenylyl Cyclase Inhibitors; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001082:Aqueous Humor / Q000187:drug effects / Q000502:physiology; D002186:Cannabinoids / Q000627:therapeutic use; D004298:Dopamine / Q000008:administration & dosage / Q000627:therapeutic use; D004837:Epinephrine / Q000031:analogs & derivatives / Q000627:therapeutic use; D005123:Eye / Q000187:drug effects; D005901:Glaucoma / Q000145:classification / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D009474:Neurons / Q000187:drug effects; D010277:Parasympathomimetics / Q000627:therapeutic use; D011453:Prostaglandins / Q000627:therapeutic use; D011941:Receptors, Adrenergic / Q000187:drug effects; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors; D013566:Sympathomimetics / Q000627:therapeutic use
D000067956:Adenylyl Cyclase Inhibitors; D000305:Adrenal Cortex Hormones; D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D002186:Cannabinoids; D010277:Parasympathomimetics; D011453:Prostaglandins; D011941:Receptors, Adrenergic; D013566:Sympathomimetics; C015173:dipivefrin; D000254:Sodium-Potassium-Exchanging ATPase; D004298:Dopamine; D004837:Epinephrine